Centiva Capital »

Keros Therapeutics shares owned by Centiva Capital

Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by Centiva Capital from 13F filings

Historical chart of Centiva Capital investment in Keros Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Keros Therapeutics held by Centiva Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Keros Therapeutics by Centiva Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $380k 24k 15.82
2025-06-30 $320k 24k 13.35
2025-03-31 $1.9M 191k 10.19

More positions owned by Centiva Capital

Ishares Tr Russell 2000 Etf (IWM)
NVIDIA Corporation (NVDA)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Alibaba Group Hldg Sponsored Ads Call Option (BABA)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Tesla Motors (TSLA)
Regeneron Pharmaceuticals Call Option (REGN)
Pdd Holdings Sponsored Ads (PDD)
Microsoft Corporation (MSFT)
Eli Lilly & Co. (LLY)
Meta Platforms Cl A (META)
Amazon (AMZN)
Kraneshares Trust Csi Chi Internet Put Option (KWEB)
Apple Call Option (AAPL)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)

View all positions for Centiva Capital

Top funds holding Keros Therapeutics

ADAR1 Capital Management
Vanguard Group
BlackRock
Madison Avenue Partners
Western Standard
Nantahala Capital Management
Tang Capital Management
D. E. Shaw & Co
Goldman Sachs Group
State Street Corporation
OrbiMed Advisors
Morgan Stanley
Alkeon Capital Management
Logos Global Management
Geode Capital Management

View all funds holding Keros Therapeutics